EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular biomarkers involved in the progression of gallbladder inflammatory lesions to invasive cancer: A proteomic approach

Neetu Rawal, Gururao Hariprasad, Sabyasachi Bandyopadhyay, Nihar Ranjan Dash, Sunil Kumar, Prasenjit Das, Sharmistha Dey, Maroof Ahmad Khan, Amar Ranjan, Anita Chopra, Sundeep Saluja, Showket Hussain und 3 weitere

Biomolecules and Biomedicine · 08.09.2024 · 25 (1) · 115-143

DOI: 10.17305/bb.2024.10704 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules and Biomedicine, online erschienen am 08.09.2024. Verfasst von Neetu Rawal und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Oncology Unit, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Gallbladder Neoplasms, Proteomics, Biomarkers, Tumor, Disease Progression. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The progression of gallbladder inflammatory lesions to invasive cancer remains poorly understood, necessitating research on biomarkers involved in this transition. This study aims to identify and validate proteins associated with this progression, offering insights into potential diagnostic biomarkers for gallbladder cancer (GBC). Label-free liquid chromatography-assisted tandem mass spectrometry (LC-MS/MS) proteomics was performed on samples from ten cases each of GBC and inflammatory lesions, with technical duplicates. Validation was conducted through the enzyme-linked immunosorbent assay (ELISA) using 80 samples (40 GBC and 40 inflammatory lesions). Bioinformatics tools analyzed protein–protein interaction (PPI) networks and pathways. Statistical correlations with clinicopathological variables were assessed. Prognostic evaluation utilized Kaplan–Meier survival analysis and Cox regression analyses. mRNA expressions were studied using real-time-polymerase chain reaction (RT-PCR). Out of 5714 proteins analyzed, 621 were differentially expressed. Three upregulated (the S100 calcium-binding protein P [S100P], polymeric immunoglobulin receptor [PIGR], and complement C1q-binding protein [C1QBP]) and two downregulated (transgelin [TAGLN] and calponin 1 [CNN1]) proteins showed significant expression. Pathway analysis implicated involvement of proteoglycans in cancer and glycosaminoglycan metabolism. Significant correlations were observed between protein concentrations and clinicopathological variables. Prognostic factors, such as tumor size, lymph node metastasis, and preoperative bilirubin levels were associated with overall survival (OS). Protein-based assays demonstrated higher resolution compared to mRNA analysis, suggesting their utility in GBC risk stratification. S100P, PIGR, C1QBP, TAGLN, and CNN1 emerge as potential protein-based biomarkers involved in the progression from gallbladder inflammatory lesions to invasive cancer. These findings hold promise for improved diagnostic and prognostic strategies in GBC management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gallbladder NeoplasmsProteomicsBiomarkers, TumorDisease ProgressionHumansMaleFemaleMiddle AgedAgedNeoplasm InvasivenessProtein Interaction MapsPrognosisInflammationTandem Mass SpectrometryGallbladder

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Laboratory Oncology Unit, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India.
  • Proteomics Laboratory, Centralized Core Research Facility, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Gastrointestinal Surgery, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Surgical Oncology, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.

Zitieren

APA

Rawal, N., Hariprasad, G., Bandyopadhyay, S., Ranjan Dash, N., Kumar, S., Das, P., Dey, S., Ahmad Khan, M., Ranjan, A., Chopra, A., Saluja, S., Hussain, S., Rath, G. K., Kaur, T., & Tanwar, P. (2024). Molecular biomarkers involved in the progression of gallbladder inflammatory lesions to invasive cancer: A proteomic approach. Biomolecules and Biomedicine, 25(1), 115-143. https://doi.org/10.17305/bb.2024.10704

Vancouver

Rawal N, Hariprasad G, Bandyopadhyay S, Ranjan Dash N, Kumar S, Das P, et al. Molecular biomarkers involved in the progression of gallbladder inflammatory lesions to invasive cancer: A proteomic approach. Biomolecules and Biomedicine. 2024;25(1):115-143. doi:10.17305/bb.2024.10704

BibTeX
@article{Rawal2024,
  author = {Rawal, Neetu and Hariprasad, Gururao and Bandyopadhyay, Sabyasachi and Ranjan Dash, Nihar and Kumar, Sunil and Das, Prasenjit and Dey, Sharmistha and Ahmad Khan, Maroof and Ranjan, Amar and Chopra, Anita and Saluja, Sundeep and Hussain, Showket and Rath, G K and Kaur, Tanvir and Tanwar, Pranay},
  title = {Molecular biomarkers involved in the progression of gallbladder inflammatory lesions to invasive cancer: A proteomic approach},
  journal = {Biomolecules and Biomedicine},
  year = {2024},
  volume = {25},
  number = {1},
  pages = {115--143},
  doi = {10.17305/bb.2024.10704}
}
Kostenlos starten →